• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD NEXIVA DIFFUSICS 18G X 1.25 IN; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD NEXIVA DIFFUSICS 18G X 1.25 IN; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383594
Medical Device Problem Code Defective Component (2292)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/15/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Event or Problem Description
It was reported that bd nexiva diffusics 18g x 1.25 in catheter is defective / damaged.It was reported by customer that they are not able to use diffusics 18g catheters for cardiac scans at 6ml/sec at 325psi because they are immediately pressuring out.Texas health frisco ct department is not able to use diffusics 18g catheters for cardiac scans at 6ml/sec at 325psi because they are immediately pressuring out.The lot number is #2290249.We did a variety of tests including power injecting contrast over a trash can with diffusics with a competitor nfc, diffusics with no nfc, diffusics with max, diffusics xl with max, diffusics xl with no nfc, as well as a 20g diffusics.Their power injector was recently calibrated and their contrast tubing is rated for 400psi.
 
Additional Manufacturer Narrative
Investigation results: a device history record review was completed by our quality engineer team for provided material number 383594 and lot number 2290249.The review did not reveal any detected abnormalities during the production process that could have contributed to this defect and all quality tests were found to be within specification.As a sample was unavailable for return, a thorough sample investigation could not be completed.Based on the investigation results, an exact cause for this incident could not be identified.There are quality controls currently in place to detect this type of defect during the production process.Further action has not been determined necessary at this time.Complaints received for this device and reported condition will continue to be tracked and trended.Our quality team regularly reviews the collected data for identification of emerging trends.
 
Event or Problem Description
No additional information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA DIFFUSICS 18G X 1.25 IN
Common Device Name
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
Manufacturer (Section G)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX  
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key21303998
Report Number9610847-2025-00015
Device Sequence Number8884323
Product Code FOZ
UDI-Device Identifier00382903835942
UDI-Public(01)00382903835942(11)221109(17)251031(10)2290249
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K173354
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 02/25/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2025
Device Catalogue Number383594
Device Lot Number2290249
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/15/2025
Supplement Date Received by Manufacturer02/25/2025
Initial Report FDA Received Date02/04/2025
Supplement Report FDA Received Date02/25/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/09/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-